A prospective trial of safety and efficacy of low-dose tacrolimus therapy in steroid resistant nephrotic syndrome

A prospective trial of safety and efficacy of low-dose tacrolimus therapy in steroid resistant nephrotic syndrome

Introduction: A Significant proportion of steroid-resistant nephrotic syndrome (SRNS) patients who do not achieve remission will progress to end-stage renal disease (ESRD). Objectives: Calcineurin inhibitors (CNIs) are recommended as a first line therapy in SRNS but the data on tacrolimus (TAC) and...

Full description

Bibliographic Details
Main Authors: Avinandan Banerjee, Smita Subhash Divyaveer, Praveen Malvade, Tanima Das Bhattacharya, Chetan Mahajan, Vaibhav Tiwari, Arpita Raychaudhury, Dipankar Sircar, Sanjay Dasgupta, Arunansu Bandyopadhyay, Debabrata Sen, Rajendra Pandey
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2018-01-01
Series:Journal of Nephropharmacology
Subjects:
Steroid resistant nephrotic syndrome
Minimal change disease
Focal segmental glomerulosclerosis
Tacrolimus
Kidney biopsy
Trough level
Interstitial fibrosis
Tubular atrophy
Online Access:http://jnephropharmacology.com/PDF/npj-7-18.pdf

Internet

http://jnephropharmacology.com/PDF/npj-7-18.pdf

Similar Items